FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:2643-2653 December 22, 2005 Number 25 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Cefalu, W. T. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background Intensive diabetes therapy aimed at achieving near normoglycemia reduces the risk of microvascular and neurologic complications of type 1 diabetes. We studied whether the use of intensive therapy as compared with conventional therapy during the Diabetes Control and Complications Trial (DCCT) affected the long-term incidence of cardiovascular disease.

Methods The DCCT randomly assigned 1441 patients with type 1 diabetes to intensive or conventional therapy, treating them for a mean of 6.5 years between 1983 and 1993. Ninety-three percent were subsequently followed until February 1, 2005, during the observational Epidemiology of Diabetes Interventions and Complications study. Cardiovascular disease (defined as nonfatal myocardial infarction, stroke, death from cardiovascular disease, confirmed angina, or the need for coronary-artery revascularization) was assessed with standardized measures and classified by an independent committee.

Results During the mean 17 years of follow-up, 46 cardiovascular disease events occurred in 31 patients who had received intensive treatment in the DCCT, as compared with 98 events in 52 patients who had received conventional treatment. Intensive treatment reduced the risk of any cardiovascular disease event by 42 percent (95 percent confidence interval, 9 to 63 percent; P=0.02) and the risk of nonfatal myocardial infarction, stroke, or death from cardiovascular disease by 57 percent (95 percent confidence interval, 12 to 79 percent; P=0.02). The decrease in glycosylated hemoglobin values during the DCCT was significantly associated with most of the positive effects of intensive treatment on the risk of cardiovascular disease. Microalbuminuria and albuminuria were associated with a significant increase in the risk of cardiovascular disease, but differences between treatment groups remained significant (P0.05) after adjusting for these factors.

Conclusions Intensive diabetes therapy has long-term beneficial effects on the risk of cardiovascular disease in patients with type 1 diabetes.

Source Information

The Writing Committee — David M. Nathan, M.D. (chair), Patricia A. Cleary, M.S., Jye-Yu C. Backlund, M.S., Saul M. Genuth, M.D., John M. Lachin, D.Sc., Trevor J. Orchard, M.D., Philip Raskin, M.D., and Bernard Zinman, M.D. — vouches for the accuracy and integrity of the data.

Address reprint requests to the DCCT/EDIC Research Group at Box NDIC/DCCT, Bethesda, MD 20892, or at dnathan{at}partners.org.

Full Text of this Article

Related Letters:

Intensive Diabetes Treatment and Cardiovascular Disease
Weissman A. J., Ross P. S., Nathan D. M., Genuth S., Lachin J., Cefalu W. T.
Extract | Full Text | PDF  
N Engl J Med 2006; 354:1751-1752, Apr 20, 2006. Correspondence

This article has been cited by other articles:

• Chalmers, J., Cooper, M. E. (2008). UKPDS and the Legacy Effect. NEJM 359: 1618-1620 [Full Text]  
• The Juvenile Diabetes Research Foundation Continuo, (2008). Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes. NEJM 359: 1464-1476 [Abstract] [Full Text]  
• Kahn, S. E., Cefalu, W. T. (2008). Glucose Control, Macro- and Microvascular Disease, and the Food and Drug Administration: Let's Keep Our Eye on the Ball. J. Clin. Endocrinol. Metab. 93: 3727-3729 [Full Text]  
• Maile, L. A., Capps, B. E., Miller, E. C., Aday, A. W., Clemmons, D. R. (2008). Integrin-Associated Protein Association With Src Homology 2 Domain Containing Tyrosine Phosphatase Substrate 1 Regulates IGF-I Signaling In Vivo. Diabetes 57: 2637-2643 [Abstract] [Full Text]  
• Pommer, W. (2008). Prevalence of nephropathy in the German diabetes population--Is early referral to nephrological care a realistic demand today?. NDT Plus 1: iv2-iv5 [Abstract] [Full Text]  
• El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., Brownlee, M. (2008). Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 205: 2409-2417 [Abstract] [Full Text]  
• Reddy, M. A., Villeneuve, L. M., Wang, M., Lanting, L., Natarajan, R. (2008). Role of the Lysine-Specific Demethylase 1 in the Proinflammatory Phenotype of Vascular Smooth Muscle Cells of Diabetic Mice. Circ. Res. 103: 615-623 [Abstract] [Full Text]  
• Kilpatrick, E S (2008). Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J. Clin. Pathol. 61: 977-982 [Abstract] [Full Text]  
• Berg, A H, Sacks, D B (2008). Haemoglobin A1c analysis in the management of patients with diabetes: from chaos to harmony. J. Clin. Pathol. 61: 983-987 [Abstract] [Full Text]  
• Bloomgarden, Z. T. (2008). Approaches to Treatment of Type 2 Diabetes. Diabetes Care 31: 1697-1703 [Full Text]  
• Yamagishi, S.-i. (2008). Possible involvement of advanced glycation end products in carry-over benefits of atorvastatin in ASCOT-BPLA. Eur Heart J 29: 1922-1922 [Full Text]  
• Duke, D. C., Geffken, G. R., Lewin, A. B., Williams, L. B., Storch, E. A., Silverstein, J. H. (2008). Glycemic Control in Youth with Type 1 Diabetes: Family Predictors and Mediators. J Pediatr Psychol 33: 719-727 [Abstract] [Full Text]  
• Fowler, M. J. (2008). Diabetes Devices. Clin. Diabetes 26: 130-133 [Full Text]  
• Chamberlain, J. J., Small, D. (2008). Successful Use of a Single Subcutaneous Continuous Glucose Monitor Sensor for 28 Days in a Patient with Type 1 Diabetes. Clin. Diabetes 26: 138-139 [Full Text]  
• Triplitt, C., Alvarez, C. A. (2008). Best Practices for Lowering the Risk of Cardiovascular Disease in Diabetes. Diabetes Spectr. 21: 177-189 [Abstract] [Full Text]  
• Saudek, C. D., Herman, W. H., Sacks, D. B., Bergenstal, R. M., Edelman, D., Davidson, M. B. (2008). A New Look at Screening and Diagnosing Diabetes Mellitus. J. Clin. Endocrinol. Metab. 93: 2447-2453 [Abstract] [Full Text]  
• Huang, E. S., Zhang, Q., Gandra, N., Chin, M. H., Meltzer, D. O. (2008). The Effect of Comorbid Illness and Functional Status on the Expected Benefits of Intensive Glucose Control in Older Patients with Type 2 Diabetes: A Decision Analysis. ANN INTERN MED 149: 11-19 [Abstract] [Full Text]  
• Villeneuve, L. M., Reddy, M. A., Lanting, L. L., Wang, M., Meng, L., Natarajan, R. (2008). Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc. Natl. Acad. Sci. USA 105: 9047-9052 [Abstract] [Full Text]  
• Dluhy, R. G., McMahon, G. T. (2008). Intensive Glycemic Control in the ACCORD and ADVANCE Trials. NEJM 358: 2630-2633 [Full Text]  
• Mozaffarian, D., Wilson, P. W.F., Kannel, W. B. (2008). Beyond Established and Novel Risk Factors: Lifestyle Risk Factors for Cardiovascular Disease. Circulation 117: 3031-3038 [Full Text]  
• Norris, S. L., Kansagara, D., Bougatsos, C., Fu, R. (2008). Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED 148: 855-868 [Abstract] [Full Text]  
• Kodl, C. T., Seaquist, E. R. (2008). Cognitive Dysfunction and Diabetes Mellitus. Endocr. Rev. 29: 494-511 [Abstract] [Full Text]  
• Bloomgarden, Z. T. (2008). Cardiovascular Disease in Diabetes. Diabetes Care 31: 1260-1266 [Full Text]  
• Schroeder, S. A., Tayek, J. A., Gaede, P., Parving, H.-H., Pedersen, O. (2008). Multifactorial Intervention and Mortality in Type 2 Diabetes. NEJM 358: 2292-2293 [Full Text]  
• MacDonald, M. R., Petrie, M. C., Hawkins, N. M., Petrie, J. R., Fisher, M., McKelvie, R., Aguilar, D., Krum, H., McMurray, J. J.V. (2008). Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J 29: 1224-1240 [Abstract] [Full Text]  
• Dubel, G. J, Murphy, T. P (2008). The role of percutaneous revascularization for renal artery stenosis. Vasc Med 13: 141-156 [Abstract]  
• Cefalu, W. T., Watson, K. (2008). Intensive Glycemic Control and Cardiovascular Disease Observations From the ACCORD Study: Now What Can a Clinician Possibly Think?. Diabetes 57: 1163-1165 [Full Text]  
• Spinetti, G., Kraenkel, N., Emanueli, C., Madeddu, P. (2008). Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. Cardiovasc Res 78: 265-273 [Abstract] [Full Text]  
• Goldfine, A. B., Beckman, J. A. (2008). Life and Death in Denmark: Lessons About Diabetes and Coronary Heart Disease. Circulation 117: 1914-1917 [Full Text]  
• Schramm, T. K., Gislason, G. H., Kober, L., Rasmussen, S., Rasmussen, J. N., Abildstrom, S. Z., Hansen, M. L., Folke, F., Buch, P., Madsen, M., Vaag, A., Torp-Pedersen, C. (2008). Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People. Circulation 117: 1945-1954 [Abstract] [Full Text]  
• Wiegand, S., Raile, K., Reinehr, T., Hofer, S., Nake, A., Rabl, W., Holl, R. W, on behalf of the DPV-Wiss Study Group, (2008). Daily insulin requirement of children and adolescents with type 1 diabetes: effect of age, gender, body mass index and mode of therapy.. Eur J Endocrinol 158: 543-549 [Abstract] [Full Text]  
• Fowler, M. J. (2008). Microvascular and Macrovascular Complications of Diabetes. Clin. Diabetes 26: 77-82 [Full Text]  
• Rewers, M. (2008). Why Do People With Diabetes Die Too Soon?: More questions than answers. Diabetes Care 31: 830-832 [Full Text]  
• Bloomgarden, D. K., Freeman, J., DeRobertis, E. (2008). Early Patient and Clinician Experiences with Continuous Glucose Monitoring. Diabetes Spectr. 21: 128-133 [Abstract] [Full Text]  
• Hirsch, I. B. (2008). Piecing the Puzzle Together: ACCORDing to Whom?. J. Clin. Endocrinol. Metab. 93: 1161-1163 [Full Text]  
• Juutilainen, A., Lehto, S., Ronnemaa, T., Pyorala, K., Laakso, M. (2008). Similarity of the Impact of Type 1 and Type 2 Diabetes on Cardiovascular Mortality in Middle-Aged Subjects. Diabetes Care 31: 714-719 [Abstract] [Full Text]  
• Peter, R, Cox, A, Evans, M (2008). Management of diabetes in cardiovascular patients. Heart 94: 369-375 [Full Text]  
• Hirai, F. E., Moss, S. E., Klein, B. E.K., Klein, R. (2008). Relationship of Glycemic Control, Exogenous Insulin, and C-Peptide Levels to Ischemic Heart Disease Mortality Over a 16-Year Period in People With Older-Onset Diabetes: The Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). Diabetes Care 31: 493-497 [Abstract] [Full Text]  
• Ingram, D. A., Lien, I. Z., Mead, L. E., Estes, M., Prater, D. N., Derr-Yellin, E., DiMeglio, L. A., Haneline, L. S. (2008). In Vitro Hyperglycemia or a Diabetic Intrauterine Environment Reduces Neonatal Endothelial Colony-Forming Cell Numbers and Function. Diabetes 57: 724-731 [Abstract] [Full Text]  
• Despres, J.-P., Poirier, P., Bergeron, J., Tremblay, A., Lemieux, I., Almeras, N. (2008). From individual risk factors and the metabolic syndrome to global cardiometabolic risk. Eur Heart J Suppl 10: B24-B33 [Abstract] [Full Text]  
• Bloom, R. D., Crutchlow, M. F. (2008). New-Onset Diabetes Mellitus in the Kidney Recipient: Diagnosis and Management Strategies. CJASN 3: S38-S48 [Abstract] [Full Text]  
• Bhattacharyya, S., Marinic, T. E., Krukovets, I., Hoppe, G., Stenina, O. I. (2008). Cell Type-specific Post-transcriptional Regulation of Production of the Potent Antiangiogenic and Proatherogenic Protein Thrombospondin-1 by High Glucose. J. Biol. Chem. 283: 5699-5707 [Abstract] [Full Text]  
• Duan, S. Z., Usher, M. G., Mortensen, R. M. (2008). Peroxisome Proliferator-Activated Receptor-{gamma}-Mediated Effects in the Vasculature. Circ. Res. 102: 283-294 [Abstract] [Full Text]  
• Johansson, F., Kramer, F., Barnhart, S., Kanter, J. E., Vaisar, T., Merrill, R. D., Geng, L., Oka, K., Chan, L., Chait, A., Heinecke, J. W., Bornfeldt, K. E. (2008). Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. Proc. Natl. Acad. Sci. USA 105: 2082-2087 [Abstract] [Full Text]  
• Gaede, P., Lund-Andersen, H., Parving, H.-H., Pedersen, O. (2008). Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes. NEJM 358: 580-591 [Abstract] [Full Text]  
• DeVon, H. A., Penckofer, S., Larimer, K. (2008). Midwest Nursing Research Society Sage Best Paper Award: The Association of Diabetes and Older Age With the Absence of Chest Pain During Acute Coronary Syndromes. West J Nurs Res 30: 130-144 [Abstract]  
• Philips, J.-C., Marchand, M., Scheen, A. J. (2008). Squatting Amplifies Pulse Pressure Increase With Disease Duration in Patients With Type 1 Diabetes. Diabetes Care 31: 322-324 [Abstract] [Full Text]  
• Bao, S., Jacobson, D. A., Wohltmann, M., Bohrer, A., Jin, W., Philipson, L. H., Turk, J. (2008). Glucose homeostasis, insulin secretion, and islet phospholipids in mice that overexpress iPLA2{beta} in pancreatic {beta}-cells and in iPLA2{beta}-null mice. Am. J. Physiol. Endocrinol. Metab. 294: E217-E229 [Abstract] [Full Text]  
• Milicevic, Z., Raz, I., Beattie, S. D., Campaigne, B. N., Sarwat, S., Gromniak, E., Kowalska, I., Galic, E., Tan, M., Hanefeld, M. (2008). Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia. Diabetes Care 31: S155-S160 [Abstract] [Full Text]  
• Bianchi, C., Miccoli, R., Penno, G., Del Prato, S. (2008). Primary Prevention of Cardiovascular Disease in People With Dysglycemia. Diabetes Care 31: S208-S214 [Abstract] [Full Text]  
• Tomkin, G. H. (2008). Targets for Intervention in Dyslipidemia in Diabetes. Diabetes Care 31: S241-S248 [Abstract] [Full Text]  
• Peter, R., Rees, A. (2008). Review: Postprandial glycaemia and cardiovascular risk. British Journal of Diabetes & Vascular Disease 8: 8-14 [Abstract]  
• Hadler, N. M. (2008). Oral Hypoglycemics and Diabetic Nephropathy. CJASN 3: 159-162 [Full Text]  
• Cohen, R. M., LeCaire, T. J., Lindsell, C. J., Smith, E. P., D'Alessio, D. J. (2008). Relationship of Prospective GHb to Glycated Serum Proteins in Incident Diabetic Retinopathy: Implications of the glycation gap for mechanism of risk prediction. Diabetes Care 31: 151-153 [Full Text]  
• Fernandez, M., Triplitt, C., Wajcberg, E., Sriwijilkamol, A. A., Musi, N., Cusi, K., DeFronzo, R., Cersosimo, E. (2008). Addition of Pioglitazone and Ramipril to Intensive Insulin Therapy in Type 2 Diabetic Patients Improves Vascular Dysfunction by Different Mechanisms. Diabetes Care 31: 121-127 [Abstract] [Full Text]  
• American Diabetes Association, (2008). Standards of Medical Care in Diabetes--2008. Diabetes Care 31: S12-S54 [Full Text]  
• American Diabetes Association, (2008). Nutrition Recommendations and Interventions for Diabetes: A position statement of the American Diabetes Association. Diabetes Care 31: S61-S78 [Full Text]  
• Karamanlis, A., Chaikomin, R., Doran, S., Bellon, M., Bartholomeusz, F D., Wishart, J. M, Jones, K. L, Horowitz, M., Rayner, C. K (2007). Effects of protein on glycemic and incretin responses and gastric emptying after oral glucose in healthy subjects. Am. J. Clin. Nutr. 86: 1364-1368 [Abstract] [Full Text]  
• Bloomgarden, Z. T. (2007). Type 1 Diabetes and Glucose Monitoring. Diabetes Care 30: 2965-2971 [Full Text]  
• Bax, J. J., Young, L. H., Frye, R. L., Bonow, R. O., Steinberg, H. O., Barrett, E. J. (2007). Screening for Coronary Artery Disease in Patients With Diabetes. Diabetes Care 30: 2729-2736 [Abstract] [Full Text]  
• Nansel, T. R., Iannotti, R. J., Simons-Morton, B. G., Cox, C., Plotnick, L. P., Clark, L. M., Zeitzoff, L. (2007). Diabetes Personal Trainer Outcomes: Short-term and 1-year outcomes of a diabetes personal trainer intervention among youth with type 1 diabetes. Diabetes Care 30: 2471-2477 [Abstract] [Full Text]  
• Carter, R. E., Lackland, D. T., Cleary, P. A., Yim, E., Lopes-Virella, M. F., Gilbert, G. E., Orchard, T. J., for the Diabetes Control and Complications Trial/E, (2007). Intensive Treatment of Diabetes Is Associated With a Reduced Rate of Peripheral Arterial Calcification in The Diabetes Control and Complications Trial. Diabetes Care 30: 2646-2648 [Full Text]  
• Albers, J. W., Herman, W. H., Pop-Busui, R., Martin, C. L., Cleary, P., Waberski, B., for the Diabetes Control and Complications Trial (, (2007). Subclinical Neuropathy Among Diabetes Control and Complications Trial Participants Without Diagnosable Neuropathy at Trial Completion: Possible predictors of incident neuropathy?. Diabetes Care 30: 2613-2618 [Abstract] [Full Text]  
• Qaseem, A., Vijan, S., Snow, V., Cross, J. T., Weiss, K. B., Owens, D. K., for the Clinical Efficacy Assessment Subcommittee, (2007). Glycemic Control and Type 2 Diabetes Mellitus: The Optimal Hemoglobin A1c Targets. A Guidance Statement from the American College of Physicians. ANN INTERN MED 147: 417-422 [Abstract] [Full Text]  
• Shankar, A., Klein, R., Klein, B. E. K., Moss, S. E. (2007). Association between Glycosylated Hemoglobin Level and Cardiovascular and All-Cause Mortality in Type 1 Diabetes. Am J Epidemiol 166: 393-402 [Abstract] [Full Text]  
• Paterson, A. D., Rutledge, B. N., Cleary, P. A., Lachin, J. M., Crow, R. S., for the Diabetes Control and Complications Trial/E, (2007). The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care 30: 2107-2112 [Abstract] [Full Text]  
• Farmer, A., Wade, A., Goyder, E., Yudkin, P., French, D., Craven, A., Holman, R., Kinmonth, A.-L., Neil, A. (2007). Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 335: 132-132 [Abstract] [Full Text]  
• Greer, D. M., Cagliero, E., Krakauer, E. L., Gonzalez, R. G., Hedley-Whyte, E. T. (2007). Case 21-2007 -- A 58-Year-Old Woman with Headaches, Weakness, and Strokelike Episodes. NEJM 357: 164-173 [Full Text]  
• Eisenbarth, G. S. (2007). Update in Type 1 Diabetes. J. Clin. Endocrinol. Metab. 92: 2403-2407 [Abstract] [Full Text]  
• Hollander, P. (2007). Anti-Diabetes and Anti-Obesity Medications: Effects on Weight in People With Diabetes. Diabetes Spectr. 20: 159-165 [Abstract] [Full Text]  
• Ceriello, A., Piconi, L., Esposito, K., Giugliano, D. (2007). Telmisartan Shows an Equivalent Effect of Vitamin C in Further Improving Endothelial Dysfunction After Glycemia Normalization in Type 1 Diabetes. Diabetes Care 30: 1694-1698 [Abstract] [Full Text]  
• Herman, W. H. (2007). Diabetes Epidemiology: Guiding Clinical and Public Health Practice: The Kelly West Award Lecture, 2006. Diabetes Care 30: 1912-1919 [Full Text]  
• Psaty, B. M., Furberg, C. D. (2007). Rosiglitazone and Cardiovascular Risk. NEJM 356: 2522-2524 [Full Text]  
• Authors/Task Force Members:, , Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., Narkiewicz, K., Ruilope, L., Rynkiewicz, A., Schmieder, R. E., Struijker Boudier, H. A.J., Zanchetti, A., ESC Committee for Practice Guidelines (CPG):, , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., ESH Scientific Council:, , Kjeldsen, S. E., Erdine, S., Narkiewicz, K., Kiowski, W., Agabiti-Rosei, E., Ambrosioni, E., Cifkova, R., Dominiczak, A., Fagard, R., Heagerty, A. M., Laurent, S., Lindholm, L. H., Mancia, G., Manolis, A., Nilsson, P. M., Redon, J., Schmieder, R. E., Struijker-Boudier, H. A.J., Viigimaa, M., Document Reviewers:, , Filippatos, G., Adamopoulos, S., Agabiti-Rosei, E., Ambrosioni, E., Bertomeu, V., Clement, D., Erdine, S., Farsang, C., Gaita, D., Kiowski, W., Lip, G., Mallion, J.-M., Manolis, A. J., Nilsson, P. M., O'Brien, E., Ponikowski, P., Redon, J., Ruschitzka, F., Tamargo, J., van Zwieten, P., Viigimaa, M., Waeber, B., Williams, B., Zamorano, J. L. (2007). 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 0: ehm236v1-75 [Full Text]  
• Authors/Task Force Members, , Ryden, L., Standl, E., Bartnik, M., Berghe, G. V. d., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., Malmberg, K., Priori, S., Ostergren, J., Tuomilehto, J., Thrainsdottir, I., Other Contributors, , Vanhorebeek, I., Stramba-Badiale, M., Lindgren, P., Qiao, Q., ESC Committee for Practice Guidelines (CPG), , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, J., Dean, V., Deckers, J., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J., Zamorano, J. L., Document Reviewers, , Deckers, J. W., Bertrand, M., Charbonnel, B., Erdmann, E., Ferrannini, E., Flyvbjerg, A., Gohlke, H., Juanatey, J. R. G., Graham, I., Monteiro, P. F., Parhofer, K., Pyorala, K., Raz, I., Schernthaner, G., Volpe, M., Wood, D. (2007). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J Suppl 9: C3-C74 [Full Text]  
• Al-Ozairi, E., Sibal, L., Home, P. (2007). Counterpoint: A Diabetes Outcome Progression Trial (ADOPT): Good for Sulfonylureas?. Diabetes Care 30: 1677-1680 [Full Text]  
• Berikai, P., Meyer, P. M., Kazlauskaite, R., Savoy, B., Kozik, K., Fogelfeld, L. (2007). Gain in Patients' Knowledge of Diabetes Management Targets Is Associated With Better Glycemic Control. Diabetes Care 30: 1587-1589 [Full Text]  
• Margeirsdottir, H. D., Larsen, J. R., Brunborg, C., Sandvik, L., Dahl-Jorgensen, K., for the Norwegian Study Group for Childhood Diabet, (2007). Strong Association Between Time Watching Television and Blood Glucose Control in Children and Adolescents With Type 1 Diabetes. Diabetes Care 30: 1567-1570 [Abstract] [Full Text]  
• Phillip, M., Battelino, T., Rodriguez, H., Danne, T., Kaufman, F., for the Consensus forum participants, (2007). Use of Insulin Pump Therapy in the Pediatric Age-Group: Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes . Diabetes Care 30: 1653-1662 [Full Text]  
• Hsueh, W., Abel, E. D., Breslow, J. L., Maeda, N., Davis, R. C., Fisher, E. A., Dansky, H., McClain, D. A., McIndoe, R., Wassef, M. K., Rabadan-Diehl, C., Goldberg, I. J. (2007). Recipes for Creating Animal Models of Diabetic Cardiovascular Disease. Circ. Res. 100: 1415-1427 [Abstract] [Full Text]  
• Abrahamson, M. J. (2007). Intensive Glucose Control in Elderly Adults--Reply. JAMA 297: 2196-2196 [Full Text]  
• The Diabetes Control and Complications Trial/Epide, (2007). Long-Term Effect of Diabetes and Its Treatment on Cognitive Function. NEJM 356: 1842-1852 [Abstract] [Full Text]  
• Pratley, R. E, Matfin, G. (2007). Review: Pre-diabetes: clinical relevance and therapeutic approach. British Journal of Diabetes & Vascular Disease 7: 120-129 [Abstract]  
• Schrot, R. J., Patel, K. T., Foulis, P. (2007). Evaluation of Inaccuracies in the Measurement of Glycemia in the Laboratory, by Glucose Meters, and Through Measurement of Hemoglobin A1c. Clin. Diabetes 25: 43-49 [Abstract] [Full Text]  
• Skyler, J. S., Ponder, S., Kruger, D. F., Matheson, D., Parkin, C. G. (2007). Is There a Place for Insulin Pump Therapy in Your Practice?. Clin. Diabetes 25: 50-56 [Abstract] [Full Text]  
• Davidson, M. B. (2007). Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes: Response to Jellinger, Lebovitz, and Davidson . Diabetes Care 30: e18-e20 [Full Text]  
• Chaikomin, R., Wu, K. L., Doran, S., Jones, K. L., Smout, A. J. P. M., Renooij, W., Holloway, R. H., Meyer, J. H., Horowitz, M., Rayner, C. K. (2007). Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1099-G1104 [Abstract] [Full Text]